Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
P2X receptors remain investigational targets; leaves open clinical utility pending prospective trials.
P2X receptors are ligand‐gated ion channels activated by ATP. They are trimeric receptors formed from P2X subunit proteins (P2X 1–7 ), which can associate as homomers or heteromers. Among the P2X receptors, the P2X 1 receptor is most widely distributed in the cardiovascular system, being expressed on the smooth muscle of most blood vessels investigated. It mediates contraction to ATP coreleased with noradrenaline as a sympathetic neurotransmitter. P2X receptors are also expressed in the heart and mediate an increase in myocyte contractility, an effect in which the P2X 4 receptor is important. Prejunctional P2X 3 and P2X 2/3 receptors on cardiac sympathetic neurones may, through positive feedback, amplify sympathetic neurotransmission. More recently, P2X receptors have been discovered on endothelial cells with immunoreactivity for P2X 1–7 receptor proteins variously having been shown, and a role identified for the P2X 4 receptor as a mediator of endothelium‐dependent vasodilatation during shear stress. Their widespread expression in the heart and vasculature identifies P2X receptors as potential targets for the development of drugs to treat cardiovascular disease. WIREs Membr Transp Signal 2012, 1:663–674. doi: 10.1002/wmts.58 For further resources related to this article, please visit the WIREs website .
No takes yet. Share an insight, caveat, or question.
Vera Ralevic (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: